Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy

Despite modern treatment approaches, survival of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) remains low and it is difficult to identify patients who derive optimal benefit from treatment. We therefore analyzed which commonly available laboratory and cl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Magnes, Teresa, Melchardt, Thomas, Weiss, Lukas, Mittermair, Christof, Neureiter, Daniel, Klieser, Eckhard, Gampenrieder, Simon, Moser, Gerhard, Gaggl, Alexander, Greil, Richard, Egle, Alexander
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501656/
https://ncbi.nlm.nih.gov/pubmed/28686697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0180995
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller